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Available online 19 October 2016Background: Increasing studies showed that abnormal changes in single nucleotide polymorphisms (SNPs) of
DNMTs (DNMT1,DNMT3A andDNMT3B) were associatedwith occurrence or decrease of various tumors. Howev-
er, the associations betweenDNMTs variations and gastric cancer (GC) risk were still conﬂicting.We aimed to as-
sess the effect of DNMTs polymorphisms on the susceptibility to GC.
Methods: Firstly, we did a meta-analysis for 7 SNPs (rs16999593, rs2228611, rs8101866 in DNMT1, rs1550117,
rs13420827 in DNMT3A, rs1569686, rs2424913 in DNMT3B). Four genetic models (homozygote, heterozygote,
dominant and recessive model) were used. Moreover, a meta-sensitivity and subgroup analysis was performed
to clarify heterogeneity source. Lastly, 17 SNPs that couldn't be meta-analyzed were presented in a systematic
review.
Findings: 20 studies were included, 13 studies could bemeta-analyzed and 7 ones could not. Firstly, a meta-anal-
ysis on 13 studies (3959 GC cases and 5992 controls) for 7 SNPs showed that GC risk increased in rs16999593
(heterozygotemodel: OR1.36, 95%CI 1.14–1.61; dominantmodel: OR1.36, 95%CI 1.15–1.60) and rs1550117 (ho-
mozygote model: OR 2.03, 95%CI 1.38–3.00; dominant model: OR 1.20, 95%CI 1.01–1.42; recessive model: OR
1.96, 95%CI 1.33–2.89) but decreased in rs1569686 (dominant model: OR 0.74, 95%CI 0.61–0.90). The remaining
SNPs were not found associated with GC risk. Furthermore, the subgroup analysis indicated that for rs1550117
and rs1569686, the signiﬁcant associations were particularly found in people from Chinese Jiangsu province
(rs1550117, OR 1.77, 95%CI 1.25–2.51; rs1569686, OR 0.48, 95%CI 0.36–0.64) and that PCR-RFLP was a sensitive
method to discover signiﬁcant associations (rs1550117, OR 1.77, 95%CI 1.25–2.51; rs1569686, OR 0.49, 95%CI
0.37–0.65). Lastly, a systematic review on 7 studies for 17 SNPs suggested that rs36012910, rs7560488 and
rs6087990 might have a potential effect on GC initiation.
Conclusion: This meta-analysis demonstrated that rs16999593 and rs1550117 could contribute to GC risk and
that rs1569686 might be a protective factor against gastric carcinogenesis. By using these SNPs as biomarkers,
it is feasible to estimate the risk of acquiring GC and thus formulate timely preventive strategy.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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In 2012, 951,000 new gastric cancer (GC) cases and 723,000 deaths
were estimated worldwide, making it the ﬁfth most common tumor
(Ferlay et al., 2015; Torre et al., 2015). GC is a complex disease arising
from environmental and genetic factors. However in individuals infect-
ed with H. pylori, deﬁned as a deﬁnite gastric carcinogen (Yang, 2006),
only a few eventually develop into GC, which suggested that hostshi_qi@hotmail.com (Q. Shi).
. This is an open access article undergenetic factors may play a crucial role in the susceptibility of GC (Saeki
et al., 2013).
The epigenetics is believed to be important in the development of
cancers, which was deﬁned as a stably heritable changes through mod-
ifying gene expression without DNA sequence alterations (Esteller,
2008). The most common epigenetic phenomenon is DNA methylation
that refers to amethyl group is conferred to the5′ carbon of a cytosine in
a CpGdinucleotide. It is catalyzed by a family of DNAmethyltransferases
(DNMTs) mainly consisting of three activated forms: DNMT1, DNMT3A
and DNMT3B. DNMT1 is thought to be a maintenance DNA methyl-
transferase which principally maintains CpG methylation, involving in
embryonic development and somatic cells survival (Brown and
Robertson, 2007) and it is encoded by DNMT1 gene which locates onthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Flow chart of study selection process.
126 H. Li et al. / EBioMedicine 13 (2016) 125–131chromosome 19p13.2 (Jiang et al., 2012a). DNMT3A and DNMT3B are
considered as de novomethyltransferaseswhich are required for the es-
tablishment of embryonic methylation patterns, mainly occurring dur-
ing gametogenesis and early development (Okano et al., 1999) and
they are encoded by DNMT3A and DNMT3B genes locating on chromo-
some 2p23 and 20q11.2 respectively (Yang et al., 2012).
There is considerable evidence that a number of abnormal changes
in single nucleotide polymorphisms (SNPs) of DNMTs (DNMT1,
DNMT3A and DNMT3B), which could cause DNA hypo-methylation or
hyper-methylation (Gao et al., 2011; Fu et al., 2010; Harder et al.,Table 1
Characteristics of 13 studies included in the meta-analysis.
Study Province/Country Ascertainment of
cases
Source of
controls
Gen
met
Yan et al., 2015 Shandong/China Histological HB Seq
Yang et al., 2012 Jiangxi/China Histological HB Mas
Jiang et al.,
2012a, b
Jilin/China Histological HB Taq
Khatami et al.,
2009
Fars/Iran, Tork/Iran Histological HB PCR
Cao et al., 2013 Jilin/China Histological HB Taq
Fan et al., 2010 Jiangsu/China Histological HB/PB PCR
Liu, 2009 Jiangsu/China NA NA PCR
Wang et al.,
2015a, b
Jilin/China Histological HB Taq
Zhang et al.,
2014
Heilongjiang/China NA NA PCR
Hu et al., 2010 Jiangsu/China Histological HB/PB PCR
Zhang, 2008 Jiangsu/China NA HB PCR
Wang et al.,
2005
Hebei/China Histological HB/PB PCR
Aung et al., 2005 Hiroshima/Japan,
Yamaguchi/Japan
Histological HB PCR
NA, not available; HB, hospital based; PB, population based; PCR-RFLP, polymorphism chain reac
yltransferase genes; SNPs, single nucleotide polymorphisms; HWE, Hardy-Weinberg equilibriu2008; Zhao and Bu, 2012), are correlated to tumor occurrence or de-
crease (Luo et al., 2015; Chang et al., 2014; Mostowska et al., 2013;
Kullmann et al., 2013; Sun et al., 2012; Xiang et al., 2010; Kanai et al.,
2003) such as head and neck cancer, and colorectal cancer (Zhu et al.,
2015; Duan et al., 2015). However, the associations between DNMTs
SNPs and GC risk were still conﬂicting (Jiang et al., 2012a; Yang et al.,
2012). Therefore, for the ﬁrst time, the effects ofDNMTs polymorphisms
on the susceptibility to GC were systematically and comprehensively
estimated.
2. Materials and Methods
2.1. Search
We did a literature search of PubMed, MEDLINE, Embase, Sinomed,
CNKI, and WanFang databases to identify relevant studies up to June
1, 2016, using the search strategy: (stomach OR gastric) AND (neo-
plasms OR tumors OR cancers OR carcinomas) AND (DNMT1 OR
DNMT3AORDNMT3BORDNMTsORDNAmethyltransferases). The lan-
guages were limited to English and Chinese. The search strategy for
PubMed was listed in Appendix A.
2.2. Selection Criteria
All studies included in themeta-analysis were accordedwith the fol-
lowing inclusion criteria: (a). study focused on the association ofDNMTs
polymorphisms andGC risk; (b). case-control or cohort studies. In addi-
tion, exclusion criteria were as follows: (a). reviews or meta-analysis;
(b). overlapped articles or studies with overlapping data.
2.3. Data Extraction
Two investigators independently extracted the following data: ﬁrst
author, year of publication, province/country of origin, ascertainment
of cases, source of controls, genotyping methods, DNMT genes, SNPs,otyping
hods
Gene SNPs Sample size
(cases/controls)
HWE
(controls)
Score
uencing DNMT1 rs16999593 310/420 0.469 9
rs2228611 0.423
sArray DNMT1 rs16999593 242/294 0.120 9
rs2228611 0.068
rs8101866 0.747
DNMT3A rs1550117 0.444
rs13420827
Man DNMT1 rs16999593 447/961 0.910 9
rs8101866
-RFLP DNMT1 rs2228611 200/200 0.187 9
Man DNMT3A rs1550117 447/961 0.658 9
rs13420827 0.833
-RFLP DNMT3A rs1550117 208/346 0.205 12
-RFLP DNMT3B rs2424913 308/189 0.942 6
rs1569686 313/350 N0.05
Man DNMT3B rs1569686 447/961 0.001 7
-RFLP DNMT3B rs1569686 50/60 0.389 4
-RFLP DNMT3B rs2424913 259/262 0.926 12
rs1569686 0.901
-RFLP DNMT3B rs2424913 156/156 0.968 6
rs1569686 0.001
-RFLP DNMT3B rs2424913 212/294 0.654 12
-RFLP DNMT3B rs2424913 152/247 1.000 6
tion-restriction fragment length polymorphism;DNMT genes, deoxyribonucleic acidmeth-
m.
127H. Li et al. / EBioMedicine 13 (2016) 125–131number of cases and controls, and value of HWE. To ensure accuracy of
the data, inconsistencies were discussed with another reviewer until
reach a consensus.2.4. Quality Assessment
The quality of each study was assessed according to the quality as-
sessment criteria (Table S1) (Thakkinstian et al., 2011; Xue et al.,
2015), in which the overall quality scores ranged from 0 to 15. Studies
with scores ≥9were regarded as high quality studies; otherwise, studies
were considered to have a low quality.Table 2
Meta-analysis of association between DNMTs SNPs and gastric cancer risk.
SNPs N (cases/controls) OR (95%CI) PORa I2 Phetb
DNMT1 rs16999593
TC vs. TTc 949/1609 1.36 (1.14,1.61) 0.001 0.0% 0.540
CC vs. TTd 654/1202 1.36 (0.93,1.99) 0.117 0.0% 0.743
TC/CC vs. TTe 999/1675 1.36 (1.15,1.60) 0.000 0.0% 0.720
CC vs. TC/TTf 999/1675 1.22 (0.84,1.78) 0.303 0.0% 0.635
DNMT1 rs2228611
GA vs. GGc 656/804 1.09 (0.88,1.36) 0.408 0.0% 0.732
AA vs. GGd 427/537 0.87 (0.60,1.27) 0.478 11.0% 0.3252.5. Data Analysis
Stata software (version 12.0; Stata Corporation, College Station, TX)
was used to perform all analysis. We used four types of genetic models
(Lieb et al., 2006): homozygote model (homozygous rare vs. homozy-
gous frequent allele), heterozygote model (heterozygous vs. homozy-
gous frequent allele), dominant model (homozygous rare +
heterozygous vs. homozygous frequent allele) and recessivemodel (ho-
mozygous rare vs. heterozygous + homozygous frequent allele). Asso-
ciation between DNMTs polymorphisms and the GC risk was evaluated
by pooled odds ratios (OR), 95% conﬁdence interval (95% CI) and P
value of Z test (POR). If 95%IC across 1 or POR b 0.05, a signiﬁcant associ-
ation existed. Then if OR or 95%IC b 1, themutant genewas a protective
factor; otherwise, it was a risk factor. Heterogeneity was analyzed using
the P value of Q test (Phet) and I2. If Phet b 0.1 or I2 N 50%, a signiﬁcant het-
erogeneity existed. And then a sensitivity analysis and a subgroup anal-
ysis were performed. Sensitivity analysis was conducted through
omitting one study by turns (Lu et al., 2016), if the 95%CI markedly de-
viated from the original interval or the I2 largely decreased, this study
was an originator of heterogeneity.GA/AA vs. GGe 752/912 1.05 (0.86,1.29) 0.622 0.0% 0.987
AA vs. GA/GGf 752/912 0.97 (0.71,1.32) 0.829 56.9% 0.098
DNMT1 rs8101866
TC vs. TTc 643/1159 0.99 (0.81, 1.21) 0.926 48.2% 0.165
CC vs. TTd 411/751 0.80 (0.55,1.17) 0.252 0.0% 0.452
TC/CC vs. TTe 686/1255 0.96 (0.80, 1.16) 0.662 0.0% 0.324
CC vs. TC/TTf 686/1255 0.80 (0.55,1.17) 0.252 13.1% 0.283
DNMT3A rs1550117
GA vs. GGc 839/1548 1.12 (0.93,1.33) 0.229 0.0% 0.436
AA vs. GGd 605/1102 2.03 (1.38,3.00) 0.000 86.9% 0.000
GA/AA vs. GGe 1104/1892 1.20 (1.01,1.42) 0.038 69.0% 0.040
AA vs. GA/GGf 896/1601 1.96 (1.33,2.89) 0.001 85.8% 0.001
DNMT3A rs13420827
CG vs. CCc 656/1206 0.84 (0.68,1.03) 0.090 44.3% 0.180
GG vs. CCd 495/851 1.16 (0.73,1.85) 0.523 0.0% 0.423
CG/GG vs. CCe 689/1255 0.87 (0.72,1.06) 0.171 0.0% 0.336
GG vs. CG/CCf 689/1255 1.23 (0.78,1.95) 0.371 0.0% 0.320
DNMT3B rs2424913
CT vs. TTc 1086/1053 0.66 (0.32,1.36) 0.258 0.0% 0.992
CC vs. TTd 1075/1032 3.02 (0.12,74.69) 0.500 – –
CT/CC vs. TTe 1087/1053 0.71 (0.35,1.44) 0.346 0.0% 0.849
CC vs. CT/TTf 1087/1053 3.02 (0.12,74.69) 0.500 – –
DNMT3B rs1569686
GT vs. TTc 745/1262 0.88 (0.69,1.13) 0.320 83.7% 0.002
GG vs. TTd 644/1072 0.96 (0.46,2.01) 0.923 3.1% 0.310
GT/GG vs. TTe 1225/1789 0.74 (0.61,0.90) 0.003 80.1% 0.000
GG vs. GT/TTf 756/1283 0.97 (0.46,2.02) 0.930 0.0% 0.394
The bolds pointed to models that had statistically signiﬁcant associations with gastric
cancer.
a P value of the Z-test for odds ration test.
b P value of the Q-test for heterogeneity test.
c Heterozygote model (heterozygous vs. homozygous frequent allele).
d Homozygote model (homozygous rare vs. homozygous frequent allele).
e Dominantmodel (homozygous rare+heterozygous vs. homozygous frequent allele).
f Recessive model (homozygous rare vs. heterozygous+ homozygous frequent allele).3. Results
3.1. Literature Search and Study Characteristics
A total of 350 records were identiﬁed through database searching.
After removing duplicates, 274 records were screened on details of the
abstracts. In those 249 publications were excluded because 5 were
meta-analysis and the other 244 were not related to DNMTs SNPs and
GC risk. Then 25 full-text articles were obtained to be assessed, in
which 5 articles were excluded because 1 was duplicate publication
and 4 did not contain information on DNMTs SNPs and GC risk. Ulti-
mately, 20 eligible studies (Jiang et al., 2012a; Yang et al., 2012; Yan et
al., 2015; Khatami et al., 2009; Wu et al., 2014; Cao et al., 2013; Wu et
al., 2012; Fan et al., 2010; Liu, 2009; Zhang et al., 2014; Hu et al., 2010;
Zhang, 2008; Liu, 2008; Wang et al., 2005; Aung et al., 2005; Wang et
al., 2015a; Jiang et al., 2013; Jiang et al., 2012b; Cao et al., 2012; Chang
et al., 2010)were included in the qualitative synthesis, and 7 of them
could not be quantitatively synthesized (3 studies respectively reported
a different SNP (Wu et al., 2014; Wu et al., 2012; Liu, 2008), 4 studies
were conference abstracts (Jiang et al., 2013; Jiang et al., 2012b; Cao et
al., 2012; Chang et al., 2010)), so 13 studies involving 3959 GC cases
and 5992 healthy controls were ﬁnally included in the meta-analysis
(Fig. 1). Among the 20 studies, 18 studies were for Chinese population
(respectively from Jiangsu, Jiangxi, Hebei, Shandong, Jilin and Heilong-
jiang provinces of China), 1 study was for Iranian population (from
Fars and Tork) and another onewas for Japanese population (fromHiro-
shima and Yamaguchi). According to the quality assessment criteria
(Table S1), scores of the 13 studies (included in the meta-analysis)
were 4–12 and 8 studies were with high quality scores (Xue et al.,
2015). The main characteristics of the 13 studies were listed in Table 1.3.2. Meta-analysis and Systematic Review
The associations between DNMTs polymorphisms and gastric carci-
nogenesis were shown in Table 2 and the statistically signiﬁcant associ-
ations (only Chinese population were discovered in signiﬁcant
associations) were represented in Fig. 2. In terms of DNMT1 and
DNMT3A, GC risk increased. For rs16999593, there was an association
under heterozygote and dominant models (TC vs. TT: OR 1.36, 95%CI
1.14–1.61; TC/CC vs. TT: OR 1.36, 95%CI 1.15–1.60) but not homozygote
and recessivemodels (CC vs. TT: OR 1.36, 95%CI 0.93–1.99; CC vs. TC/TT:
OR 1.22, 95%CI 0.84–1.78). For rs1550117, the increasedGC riskwas dis-
covered under homozygote, dominant and recessivemodels (AA vs. GG:
OR 2.03, 95%CI 1.38–3.00; GA/AA vs. GG: OR 1.20, 95%CI 1.01–1.42; AA
vs. GA/GG: OR 1.96, 95%CI 1.33–2.89) but not heterozygote model (GA
vs. GG: OR 1.12, 95%CI 0.93–1.33). Conversely, GC risk decreased in
DNMT3B. For rs1569686, the association was found under dominant
model (GT/GG vs. TT: OR 0.74, 95%CI 0.61–0.90) but not heterozygote,
homozygote and recessive models (GT vs. TT: OR 0.88, 95%CI 0.69–
1.13; GG vs. TT: OR 0.96, 95%CI 0.46–2.01; GG vs. GT/TT: OR 0.97,
95%CI 0.46–2.02). Except all of the above, for rs2228611, rs8101866,
rs13420827 and rs2424913, no signiﬁcant associations were observed
among all of the genetic models. Lastly, for SNPs not able to be
128 H. Li et al. / EBioMedicine 13 (2016) 125–131quantitatively synthesized, the systematic review presented their asso-
ciations with GC (Table 3). Three SNPs rs36012910, rs7560488 and
rs6087990 (Wu et al., 2014; Wu et al., 2012; Liu, 2008) were reported
associated with GC and others not.
3.3. Heterogeneity Analysis (Sensitivity and Subgroup Analysis)
There was obvious heterogeneity in rs1550117 (AA vs. GG I2 86.9%,
Phet 0.000; GA/AA vs. GG: I2 69.0%, Phet 0.040; AA vs. GA/GG: I2 85.8%,
Phet 0.001) and rs1569686 (GT vs. TT: I2 83.7%, Phet 0.002; GT/GG vs.
TT: I2 80.1%, Phet 0.000). A sensitivity analysis was conducted to explore
which study primarily inﬂuenced the pooled ORs (Table S2, Fig. S1–S2).
For rs1550117, the heterogeneity was mostly caused by a study (Fan et
al., 2010), since when it was removed, 95%IC changed in direction of as-
sociation (OR 1.06, 95%CI 0.87–1.29) and heterogeneity went to zero (I2
0%, Phet 0.73). Likewise, for rs1569686,Wang et al. (2015b)was found to
be themajor originator after excluded (95%IC didn't change in direction
but heterogeneity went to zero: OR 0.49, 95%CI 0.37–0.65, I2 0%, Phet
0.88). We compared characteristics of the two studies to the other's.
Two factors were screened out to explain the heterogeneity: population
areas (Jiangsu province or others) and genotyping methods (PCR-RFLP
or others). Then a subgroup analysis was performed (Fig. 3). Population
areas: for Jiangsu population, rs1550117 and rs1569686 were associat-
ed with GC (OR 1.77, 95%CI 1.25–2.51; OR 0.48, 95%CI 0.36–0.64), but
for others (Jiangxi, Jilin and Heilongjiang provinces) no associations
were found (OR 1.06, 95%CI 0.87–1.29; OR 1.15, 95%CI 0.87–1.52).
Genotypingmethods: by PCR-RFLP, rs1550117 and rs1569686were de-
tected associated with GC (OR 1.77, 95%CI 1.25–2.51; OR 0.49, 95%CI
0.37–0.65) but by others (TaqMan and MassArray) signiﬁcantFig. 2. Forest plot of DNMT1, DNMT3A and DNMTassociations were not discovered (OR 1.06, 95%CI 0.87–1.29; OR 1.20,
95%CI 0.90–1.60).
4. Discussion
Of the seven SNPs, two (rs16999593 and rs1550117) and one
(rs1569686) were signiﬁcantly associated with GC risk indicating a
range of effects from the increased (DNMT1 and DNMT3A) to the re-
duced (DNMT3B).
4.1. DNMT1
Our results proved rs16999593 as a potential biomarker for GC suscep-
tibilitywhichwas exactly consistentwith the results on other types of can-
cers, such as breast cancer and prostate cancer (Tao et al., 2015; He et al.,
2014). In addition, we did not ﬁnd rs2228611 associated with GC, but it
was recently reported that patients carrying the mutant genotypes signif-
icantly lived longer than those bearing thewild, indicating that rs2228611
might be a positive prognostic marker for GC survival (Jia et al., 2016).
4.2. DNMT3A and DNMT3B
In terms of rs1550117, our ﬁndings opposed a previousmeta-analy-
sis and we could attribute this contradiction to differences in using ho-
mozygote models (Liu et al., 2015). For rs1569686, we consider it as a
protective factor for gastric carcinogenesis and similar results were dis-
covered in head and neck cancer, lung cancer and colorectal cancer
(Duan et al., 2015; Zhang et al., 2015; Xia et al., 2015; Zhu et al.,
2012). However, another study argued it was associated with poor3B polymorphisms associated with GC risk.
Table 3
Systematic review of associations between DNMTs SNPs and gastric cancer risk.
Study Country Sample size (cases/controls) Gene SNPs OR (95%CI)
Heterozygote model Homozygote model
Yang et al., 2012 China 242/294 DNMT1 rs2114724 C N T 1.16 (0.81, 1.68) 0.62 (0.30, 1.27)
Jiang et al., 2012a, b China 447/961 DNMT1 rs10420321 A N G 0.96 (0.66, 1.41) 1.17 (1.88,1.55)
Jiang et al., 2012a, b China 447/961 DNMT1 rs8111085 T N C 1.08 (0.88, 1.43) 1.18 (0.82, 1.69)
Jiang et al., 2012a, b China 447/961 DNMT1 rs2288349 G N A 0.93 (0.71, 1.22) 0.81 (0.50, 1.33)
Khatami et al., 2009 Iran 200/200 DNMT1 rs721186 G N A 1.12 (0.06, 16.0) –
Khatami et al., 2009 Iran 200/200 DNMT1 rs13784 G N A – –
Khatami et al., 2009 Iran 200/200 DNMT1 rs11488 A N T – –
Wu et al., 2012 China 340/251 DNMT3A rs36012910 A N G 2.44 (1.37, 4.33) 1.00 (0.98, 1.01)
Yang et al., 2012 China 242/294 DNMT3A rs13428812 A N G 0.93 (0.64, 1.35) 1.11 (0.58, 2.12)
Yang et al., 2012 China 242/294 DNMT3A rs11887120 T N C 0.96 (0.63, 1.47) 1.26 (0.76, 2.07)
Wu et al., 2014 China 405/408 DNMT3A rs7560488 T N C 1.73 (1.24, 2.41) 2.50 (1.01, 6.23)
Wang et al., 2015a, b China 447/961 DNMT3B rs6119954 G N A 1.00 (0.76, 1.31) 1.37 (0.88, 2.13)
Wang et al., 2015a, b China 447/961 DNMT3B rs4911107 A N G 0.86 (0.26, 2.88) 0.76 (0.23, 2.46)
Wang et al., 2015a, b China 447/961 DNMT3B rs4911259 G N T 0.86 (0.26, 2.89) 0.76 (0.23, 2.45)
Wang et al., 2015a, b China 447/961 DNMT3B rs8118663 A N G 1.28 (0.95, 1.72) 1.32 (0.91, 1.91)
Yang et al., 2012 China 242/294 DNMT3B rs2424908 T N C 0.98 (0.66, 1.45) 1.05 (0.64, 1.71)
Liu, 2008 China 313/350 DNMT3B rs6087990 C N T – 1.46 (1.07, 2.01)
SNPs, single nucleotide polymorphisms; heterozygote model (heterozygous vs. homozygous frequent allele); homozygote model (homozygous rare vs. homozygous frequent allele).
The bolds pointed to SNPs that had statistically signiﬁcant associations with gastric cancer.
129H. Li et al. / EBioMedicine 13 (2016) 125–131prognosis in GC cases (Wang et al., 2015a). Maybe it played different
roles in pathogenesis and prognosis. Particularly, we found in Jiangsu,
a high GC incidence area of China (Liu et al., 2007), mutant rs1550117
doubled the risk and mutant rs1569686 lowered by a half of it. Also,
even though some studies discovered TaqMan was more speciﬁc andFig. 3. Forest plot of subgroup analysis on DNMT3A rs1550117 and DNMT3B rs1569686 polym
(Jiangsu province and other provinces: Jiangxi, Jilin and Heilong Jiang provinces, in China) (A)sensitive than PCR-RFLP to detect polymorphisms or virus
(Martinez-Trevino et al., 2016; Campsall et al., 2004), we found PCR-
RFLP was so far a best method for risk detection in GC. Regarding
rs2424913, we didn't ﬁnd it associated with GC in Chinese. A review re-
ported it could signiﬁcantly decrease cancers in African but not Asianorphisms (dominant model) by population area and genetic methods. Population area
; Genetic methods (PCR-RFLP and other methods: TaqMan and MassArray) (B).
130 H. Li et al. / EBioMedicine 13 (2016) 125–131(Duan et al., 2015). It was speculated whether rs2424913 enabled Afri-
can to catch GC rather than other populations. Although some meta-
analysis studies demonstrated that rs6087990 might confer protection
against overall cancers (Duan et al., 2015; Zhang et al., 2015), but it rep-
resented an opposite effect onGC as our systematic review showed (Liu,
2008).
4.3. Strengths and Limitations
Previous meta-analysis studies primarily evaluated associations be-
tween a few SNPs and cancers without classiﬁcation, such as GC (Zhu et
al., 2015; Duan et al., 2015; Liu et al., 2015; Zhang et al., 2015; Xia et al.,
2015). The major strengths of our study was its comprehensive and sys-
tematic focus on GC and SNPs from three main types of DNMTs, 17 SNPs
in total. Also, some mistakes in previous results were corrected in our
study (Liu et al., 2015). At the same time, there were some limitations.
Firstly, signiﬁcant heterogeneities were observed for a few genetic
models. Although a sensitivity analysis and a subgroup analysis were per-
formed to clarify sources, we cannot ﬁnd all potential factors. Second the
meta-analysis ﬁndings were currently restricted to Chinese population
pending results from other populations in future studies.
5. Conclusion
Our meta-analysis suggested that DNMT1 rs16999593 and DNMT3A
rs1550117 could contribute to GC and that DNMT3B rs1569686 might
function as a protective factor against gastric carcinogenesis. By using
these signiﬁcant SNPs as biomarkers, it is feasible to estimate the risk
of catching GC and thus formulate timely preventive strategy.
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